Esophageal Monitoring Device for Assessing Mucosal Impedance

Completed

Conditions studied: GERD, Esophagitis

In brief

The investigators are looking at a novel approach to measuring gastroesophageal reflux disease (GERD) damage and reducing the need for costly and less optimal testing presently used for diagnostic and treatment purposes. The investigators will be using three custom mucosal impedance (MI) catheters, each designed to measure at slightly different spacing on the esophagus.

Key facts

Study ID

NCT01556919

Run by

Vanderbilt University

People needed

429

Starts

2012-03-01

Expected to finish

2021-07-23

Last updated by the study team

2021-08-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who are undergoing standard of care EGD with or without BRAVO placement;
• Have GERD symptoms and/or have endoscopic esophagitis

You may not qualify if…

• Use of acid suppressive therapy within last 10 days;
• Known history of Barrett's esophagus, gastric surgery, alcoholism, significant motility condition

Where it is running

• Vanderbilt University Medical Center Endoscopy Laboratory — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.